Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Terminated × Uterine Cervical Neoplasms × Cetuximab × Clear all

Phase

Status

Completed 3 Unknown 2 Withdrawn 1 Terminated 1 Recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Colorectal Neoplasms 38 Squamous Cell Carcinoma of Head and Neck 17 Head and Neck Neoplasms 16 Rectal Neoplasms 14 Colonic Neoplasms 13 Neoplasm Metastasis 9 Carcinoma, Non-Small-Cell Lung 9 Neoplasms 8 Carcinoma, Squamous Cell 8 Pancreatic Neoplasms 5 Recurrence 4 Esophageal Neoplasms 4 Laryngeal Neoplasms 3 Tongue Neoplasms 2 Stomach Neoplasms 2 Ovarian Neoplasms 2 Neoplasms, Squamous Cell 2 Mouth Neoplasms 2 Lung Neoplasms 2 Laryngeal Diseases 2 Glioma 2 Glioblastoma 2 Colorectal Cancer Metastatic 2 Breast Neoplasms 2 Adenocarcinoma of Lung 2 Adenocarcinoma Of Esophagus 2 Uterine Cervical Neoplasms 1 Salivary Gland Neoplasms 1 Pharyngeal Neoplasms 1 Peritoneal Neoplasms 1

Interventions

Cisplatin 12 pembrolizumab 9 Paclitaxel 6 Carboplatin 5 Colposcopy 4 fludarabine 3 Radiotherapy 3 Fluorodeoxyglucose F18 3 Cyclophosphamide 3 Brachytherapy 3 Biopsy 3 fludarabine phosphate 2 durvalumab 2 aldesleukin 2 adavosertib 2 Zoledronic Acid 2 Topotecan 2 Surveys and Questionnaires 2 Radiation 2 Neoadjuvant Therapy 2 Magnetic Resonance Spectroscopy 2 Interleukin-2 2 Hysterectomy 2 Gemcitabine 2 Flow Cytometry 2 Diathermy 2 Conization 2 Chemotherapy, Adjuvant 2 Bevacizumab 2 Axitinib 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00518193 2011-06-30

ERBUS

ARCAGY/ GINECO GROUP

Phase 2 Terminated

Uterine Cervical Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡